AI Could Completely Change How Fast New Drugs Are Discovered
28 Aug 2026 · 0 min

0:26
In this brief excerpt, Kevin Surace argues that the pharmaceutical industry has relied on a decades‑old, slow drug‑development paradigm, typically yielding a single blockbuster drug roughly every ten years. He claims that artificial intelligence is poised to break this cycle, enabling companies—especially AI‑focused startups—to generate blockbuster‑level candidates every one to two months. This dramatic acceleration would dramatically lower healthcare costs by flooding the market with effective therapies far more quickly than the traditional model allows.










